Research

rs963917 — RAD51B RAD51B Central European RA Variant

A 3' UTR variant in RAD51B that alters miRNA-616 binding efficiency and is associated with increased risk of rheumatoid arthritis and impaired DNA double-strand break repair in immune cells

Emerging Risk Factor Share

Details

Gene
RAD51B
Chromosome
14
Risk allele
A
Clinical
Risk Factor
Evidence
Emerging

Population Frequency

AA
9%
AG
42%
GG
49%

See your personal result for RAD51B

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

RAD51B and Rheumatoid Arthritis: When DNA Repair Shapes Immune Destiny

Your immune system requires constant genomic maintenance. Every time a T cell or B cell divides in response to an antigen, it must replicate its DNA accurately — and repair any breaks that occur. RAD51B is one of the molecular architects of this repair process, and variants in the gene's regulatory region alter how efficiently immune cells fix broken DNA. When repair falters, genomic instability in immune cells may tip the immune system toward autoimmune dysregulation.

RAD51B (RAD51 paralog B) encodes a component of the BCDX2 complex11 BCDX2 complex
a four-protein complex that loads the RAD51 recombinase onto damaged DNA
. Without RAD51B, the master recombinase RAD51 cannot efficiently assemble at double-strand break sites — the most dangerous type of DNA damage. RAD51B is expressed in bone marrow, thymus, lymph nodes, and tonsil, placing it at the center of immune cell development and maintenance.

The Mechanism

rs963917 sits in the 3' untranslated region (3' UTR)22 3' untranslated region (3' UTR)
the non-coding tail of the mRNA that controls its stability and translation efficiency
of the RAD51B gene. The 3' UTR contains binding sites for microRNAs — small non-coding RNAs that silence gene expression. The rs963917 A/G variant lies within a predicted [miR-616 | a microRNA involved in regulating cell cycle and DNA damage response genes] binding site. The G allele maintains tighter miRNA-mRNA binding (higher minimum-free energy of |23.1 kcal/mol| vs |22.2 kcal/mol| for the A allele), which may influence how strongly miR-616 suppresses RAD51B expression. Carriers of the A allele may have subtly altered RAD51B expression in immune cells, affecting the efficiency of homologous recombination repair at DNA double-strand breaks.

The Evidence

A pilot case-control study from Central European (Polish) RA patients33 pilot case-control study from Central European (Polish) RA patients
Galita et al., International Journal of Molecular Sciences, 2023
genotyped 28 DNA repair polymorphisms in 100 RA patients and 100 age- and sex-matched healthy controls. rs963917/RAD51B was among the variants significantly associated with RA occurrence, with associations observed across codominant, dominant, and recessive genetic models. The same research group followed up in a 2024 functional study44 2024 functional study
Galita et al., International Journal of Molecular Sciences, 2024
measuring actual DNA double-strand break repair capacity in peripheral blood mononuclear cells (PBMCs) from 45 RA patients and 45 controls using a bleomycin-induced DNA damage assay. Carrying rs963917 (combined with rs3784099, another RAD51B variant) was associated with OR 73.4 (95% CI 5.3–1011.05) for inefficient DSB repair — confirming that the genetic association translates into a measurable functional deficit. The extremely wide confidence interval reflects the small sample size; this finding requires independent replication in larger cohorts.

The broader RAD51B–RA connection is supported by larger studies. A GWAS meta-analysis of 17,581 RA cases and 20,160 controls55 GWAS meta-analysis of 17,581 RA cases and 20,160 controls
McAllister et al., Arthritis & Rheumatism, 2013
identified the nearby RAD51B variant rs911263 as a genome-wide significant RA susceptibility locus (OR 0.89, p=4×10⁻⁸) in anti-CCP-positive RA. A Chinese Han cohort study (965 RA patients, 2,511 controls)66 Chinese Han cohort study (965 RA patients, 2,511 controls)
Zhi et al., Scientific Reports, 2017
confirmed rs911263 association with both RA risk (OR 0.64, p=4.8×10⁻⁵) and radiographic erosion severity (OR 0.52, p=2.89×10⁻⁵). Taken together, the evidence positions the RAD51B locus as a genuine RA susceptibility region, with rs963917 representing a functional 3' UTR variant that may modulate RAD51B expression through miRNA regulation.

Practical Actions

For carriers of the A allele — particularly those with a personal or family history of autoimmune disease — the priority is protecting immune cells from genomic stress. The A allele's potential impairment of RAD51B-mediated DNA repair means that anything that increases the rate of DNA damage in lymphocytes (oxidative stress, inflammation itself, certain medications) may compound the underlying repair deficit.

Monitoring inflammatory markers and seeking early rheumatology evaluation if joint symptoms appear is especially relevant. Folate-pathway adequacy is important because folate deficiency elevates the rate of DNA strand breaks that RAD51B must repair.

Interactions

RAD51B does not act alone. The BCDX2 complex also includes RAD51C (rs28363318), RAD51D (rs3784099), and XRCC2 (rs3218536). Carrying multiple variants across the homologous recombination repair pathway may compound the per-variant effect on DSB repair efficiency. The Galita 2024 study showed that rs963917 combined with rs3784099 (RAD51D, a BCDX2 partner) produced the strongest OR for inefficient repair, suggesting a functional interaction within the complex. The nearby RAD51B variant rs911263 (the original GWAS hit) may be in partial linkage disequilibrium with rs963917, though the two variants appear to capture partially independent signals.

Genotype Interpretations

What each possible genotype means for this variant:

GG “Normal Repair Capacity” Normal

Your RAD51B regulatory region is the common protective form

The G allele maintains the canonical miR-616 binding architecture in the RAD51B 3' UTR, associated with standard regulation of RAD51B expression. RAD51B participates in the BCDX2 complex that loads RAD51 onto DNA double-strand breaks during homologous recombination repair — a pathway that is especially active in rapidly dividing immune cells. No additional surveillance is indicated on the basis of this genotype alone.

AG “Intermediate Repair Variant” Intermediate Caution

One copy of the A risk allele — modestly elevated autoimmune risk

The A allele alters the predicted miR-616 binding site in the RAD51B 3' UTR, potentially reducing RAD51B expression modestly in immune cells. In the Galita 2024 functional study, RAD51B polymorphism carriers showed measurably impaired DNA double-strand break repair in peripheral blood mononuclear cells compared to controls. For heterozygotes, the impairment is likely intermediate. The overall evidence is emerging rather than established — the pilot studies are small and the specific odds ratio for heterozygotes at rs963917 alone has not been precisely quantified.

AA “Reduced Repair Capacity” High Risk Warning

Homozygous A allele — highest risk form; DNA repair impairment most likely

AA homozygosity at the miR-616 binding site in the RAD51B 3' UTR may cause the most pronounced alteration in RAD51B expression of the three genotypes. RAD51B is essential for loading the RAD51 recombinase onto DNA double-strand breaks, particularly in dividing lymphocytes. When homologous recombination repair is impaired, DSBs may be shunted toward error-prone non-homologous end joining, increasing genomic instability in immune progenitors. The same genomic instability mechanism that increases autoimmune risk also explains why RAD51B variants have been associated with cancer susceptibility (cervical, breast) in separate studies. The RAD51B locus shows its strongest RA signal in the anti-CCP-positive subgroup, suggesting the link is particularly relevant to antibody-mediated (seropositive) forms of RA.